200
Participants
Start Date
November 30, 2025
Primary Completion Date
September 30, 2028
Study Completion Date
September 30, 2028
Doxycycline monohydrate 200 mg
"Doxycycline monohydrate 200 mg (two 100 mg pills) is used to treat or prevent infections that are strongly suspected to be caused by bacteria. Doxycycline monohydrate is an antimicrobial drug indicated for the treatment of bacterial infections, including sexually transmitted diseases. CDC recommends its use as post-exposure prophylaxis (PEP).~Blood and rectal mucosal samples will be collected before the initiation of doxycycline. Participants will be instructed to take 200 mg of doxycycline by mouth every Monday, Wednesday, and Friday. Additional doses of doxycycline will be permitted on other days if sex without a condom occurs per CDC guidance. After 12 weeks of at least thrice weekly doxycycline, blood and rectal mucosal samples will again be collected for immunologic and microbiome/resistome assays."
Observation
Standard of care. Blood and rectal mucosal samples.
Grady Health System (non-CRN), Atlanta
Hope Clinic, Atlanta
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Emory University
OTHER